While there is abundant evidence of dysfunctional ApoB signaling in obesity, type 2 diabetes 23–25, and neurodegenerative disorders 26,27, a direct causal link involving ApoB has yet to be investigated. Here, APOB is linked to type 2 diabetes mellitus.